Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL31491015

Cc1nc(N)ccc1C(F)(F)F.O=C(O)C(F)(F)F

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRP O00591 2/20 0.50
GABRD O14764 2/20 0.50
GABRA1 P14867 2/20 0.50
GABRB1 P18505 2/20 0.50
GABRG2 P18507 2/20 0.50
GABRB3 P28472 2/20 0.50
GABRA5 P31644 2/20 0.50
GABRA3 P34903 2/20 0.50
GABRA2 P47869 2/20 0.50
GABRB2 P47870 2/20 0.50
GABRA4 P48169 2/20 0.50
GABRE P78334 2/20 0.50
GABRA6 Q16445 2/20 0.50
GABRG1 Q8N1C3 2/20 0.50
GABRG3 Q99928 2/20 0.50
GABRQ Q9UN88 2/20 0.50
CXCR4 P61073 1/20 0.50
F2 P00734 3/20 0.43
PRSS1 P07477 1/20 0.43
PRSS2 P07478 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL31491055 0.94 CXCR4 (0.46) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL14108794 0.88 NOS3 (0.52) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL29937121 0.88 NOS3 (0.52) GABRPGABRDGABRA1GABRB1GABRG2
Formic Acid SCHEMBL31491006 0.85 GABRP (0.43) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL3881447 0.74 KDM4E (0.51) KDM4ESORT1
Trifluoroacetic Acid SCHEMBL27659159 0.71 CXCR4 (0.42) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL31003326 0.70 KIF11 (0.39) ALDH1A1KDM4ECFTRSORT1
SCHEMBL12019749 0.70 NOS2 (0.54) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL24360672 0.69 KDM4E (0.39) GABRPGABRDGABRA1GABRB1GABRG2
Trifluoroacetic Acid SCHEMBL30165134 0.69 GABRP (0.51) GABRPGABRDGABRA1GABRB1GABRG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025049274-A2 TETRACYCLIC DERIVATIVES, COMPOSITIONS AND METHODS THEREOF ENSEM THERAPEUTICS, INC. (US) 2025-03-06 WO disclosed